Pfizer-BioNTech COVID booster targeting Omicron BA.4/5 approved in Britain Ruchika Sharma10 Nov 2022 10:00 AM ISTThe regulator on Wednesday also approved Novavax's COVID-19 shot as a booster for adults.
Pfizer-BioNTech to test combined COVID, influenza vaccine Ruchika Sharma4 Nov 2022 3:40 PM ISTFrankfurt: Pfizer-BioNTech said they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better...
Pfizer Elranatamab gets USFDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma Ruchika Sharma4 Nov 2022 3:00 PM ISTNew York: Pfizer Inc. has announced that its investigational cancer immunotherapy, elranatamab, has received Breakthrough Therapy Designation from the...
US CDC Director experiences COVID rebound after Pfizer Paxlovid treatment Ruchika Sharma1 Nov 2022 2:00 PM ISTUS: The director of the U.S. Centers for Disease Control and Prevention (CDC), Rochelle Walensky, experienced a COVID-19 rebound after completing a...
Italian tax authorities investigate Pfizer profits Ruchika Sharma30 Oct 2022 12:15 PM ISTMilan: Italy's tax authorities are investigating profits reported by Pfizer Inc's local unit Pfizer Italia srl, two sources with knowledge of the...
Pfizer expects to quadruple US COVID vaccine price to Rs 110- Rs130 per dose Ruchika Sharma23 Oct 2022 4:07 PM ISTReuters earlier on Thursday reported that Wall Street was expecting such price hikes due to weak demand for COVID vaccines, which meant vaccine makers...
Pfizer, BioNTech report positive early data from clinical trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in 18 years and older Ruchika Sharma16 Oct 2022 4:00 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced early data from a Phase 2/3 clinical trial evaluating the safety, tolerability, and...
Pfizer gets USFDA Emergency Use Authorization for bivalent omicron booster in children aged 5 through 11 years Ruchika Sharma13 Oct 2022 4:00 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (USFDA) has granted Emergency Use Authorization...
84 Percent higher risk of cardiac-related death among males 18-39 years with MRNA vaccine: Analysis sparks fear against Pfizer, Moderna vaccine Roshni Dhar11 Oct 2022 6:30 PM ISTCreating a scare among the patients world-wide taking the mRNA-based COVID vaccine, a recent advisory has been released by the Florida Department of...
Health Bulletin 10/October/2022 Roshni Dhar10 Oct 2022 5:21 PM ISTHere are the Top health stories for the day:Maharashtra: Doctor booked for wrong sonography report after pregnant woman's deathA doctor running a...
Pfizer concludes acquisition of Global Blood Therapeutics Ruchika Sharma9 Oct 2022 12:00 PM ISTGBT is now a wholly owned subsidiary of Pfizer.
Pfizer-BioNTech Omicron retooled booster authorised in Canada Ruchika Sharma8 Oct 2022 1:17 PM ISTRegulators in the European Union and Japan have also cleared Pfizer's updated booster shot.
